Immunohistochemical determination of in vivo distribution of Bax, a dominant inhibitor of Bcl-2

Stanislaw Krajewski, Maryla Krajewska, Ahmed Shabaik, Toshiyuki Miyashita, Hong Gang Wang, John C. Reed

Research output: Contribution to journalArticle

646 Scopus citations

Abstract

The protein encoded by the bcl-2 gene is a regulator of programmed cell death and apoptosis. The cell survival-promoting activity of this protein is opposed by Bax, a homologous protein that forms heterodimers with Bcl-2 and accelerates rates of cell death. In this report, the in vivo patterns of bax gene expression were immunohistochemically assessed in the mouse, with a polyclonal antibody raised against a synthetic peptide corresponding to a unique region in the murine Bax protein. Direct comparisons were made with Bcl-2 by using anti-peptide antisera specific for the mouse Bcl-2 protein. The expression of bax was more widespread than bcl-2. For example, Bax immunoreactivity was present in the hepatocytes of the liver, the exocrine pancreas, and the renal tubule epithelial cells whereas Bcl-2 was absent from these tissues. Both the Bax and Bcl-2 proteins were present in several epithelia examined, including the small intestines, colon, breast, prostate, respiratory tract, and skin. The most intense Bax immunostaining was seen in cells located in the base of the crypts of the small intestinal mucosa, consistent with reports of high rates of spontaneous and inducible apoptosis in this region. Bcl-2 immunostaining was completely absent from these cells but was present in the absorptive epithelial cells of the small intestine. In contrast, Bax immunostaining in the colon tended to be stronger in the surface epithelial cells that had advanced up the crypts towards the lumen and that are destined for programmed cell death, whereas Bcl-2 immunoreactivity generally was stronger in the base of the colonic crypts. Similarly, bax expression in the gastric pits of the stomach occurred in a gradient such that higher levels of Bax immunostaining were found in the upper layers of gastric glands than in the lower regions. In addition, strong Bax immunostaining was detected in the androgen-dependent secretary epithelial cells of the prostate, whereas Bcl-2 was limited to the androgen- independent basal cells. Like Bcl-2, Bax was found in the thymic medulla but not the cortex, despite the propensity for immature cortical thymocytes to undergo apoptosis. Unlike Bcl-2, however, Bax immunostaining tended to be more intense in the germinal center lymphocytes of lymph nodes than in the interfollicular lymphocytes, consistent with the high rate of apoptotic cell death in the former. In the nervous system, intense Bax immunostaining was seen in several populations of neurons, including the Purkinje cells of the cerebellum, large neurons of the cortex and brain stem, and neurons of sympathetic ganglia. Taken together, these results demonstrate that the patterns of bax and bcl-2 gene expression in vivo are only partially overlapping and suggest that the Bax protein is sometimes but not always localized to tissues characterized by high apoptotic death rates.

Original languageEnglish (US)
Pages (from-to)1323-1336
Number of pages14
JournalAmerican Journal of Pathology
Volume145
Issue number6
StatePublished - Dec 1 1994

All Science Journal Classification (ASJC) codes

  • Pathology and Forensic Medicine

Fingerprint Dive into the research topics of 'Immunohistochemical determination of in vivo distribution of Bax, a dominant inhibitor of Bcl-2'. Together they form a unique fingerprint.

  • Cite this

    Krajewski, S., Krajewska, M., Shabaik, A., Miyashita, T., Wang, H. G., & Reed, J. C. (1994). Immunohistochemical determination of in vivo distribution of Bax, a dominant inhibitor of Bcl-2. American Journal of Pathology, 145(6), 1323-1336.